Related Experiment Videos
Inherited hemolytic anemia: a possessive beginner's guide
1New York Blood Center, New York, NY.
Hematology. American Society of Hematology. Education Program
|December 4, 2018
Summary
Advances in diagnosing and managing inherited red cell membrane disorders like hereditary spherocytosis and elliptocytosis have been made. Splenectomy benefits HS/HE but not HX/OHS due to thrombosis risks.
Area of Science:
- Hematology
- Genetics
- Cell Biology
Background:
- Inherited red cell membrane disorders cause hemolytic anemia.
- These disorders include hereditary spherocytosis (HS), hereditary elliptocytosis (HE), hereditary xerocytosis (HX), and hereditary overhydrated stomatocytosis (OHS).
- Defects can be structural (HS, HE) or functional (HX, OHS).
Purpose of the Study:
- To review advances in the diagnosis and clinical management of inherited red cell membrane disorders.
- To differentiate management strategies based on disorder type.
Main Methods:
- Review of current literature on red cell membrane disorders.
- Analysis of diagnostic criteria and treatment outcomes.
- Comparison of management approaches for different subtypes.
Main Results:
- Hereditary spherocytosis and elliptocytosis severity correlates with membrane loss and cell sphericity.
- Splenectomy ameliorates anemia in HS and HE by increasing red cell lifespan.
- Hereditary xerocytosis and overhydrated stomatocytosis involve altered cation permeability and cell volume.
- Splenectomy is ineffective and risky for HX and OHS, increasing thrombosis risk.
Conclusions:
- Rational diagnostic and management approaches are available for inherited red cell membrane disorders.
- Splenectomy is a beneficial treatment for HS and HE but contraindicated for HX and OHS.
- Understanding the underlying membrane defect is crucial for effective patient management.